Free Trial

Clarivate (CLVT) Competitors

Clarivate logo
$4.40 +0.10 (+2.33%)
As of 03:59 PM Eastern

CLVT vs. RTO, FTAI, CART, ICLR, STN, MEDP, WPP, HQY, BILI, and LYFT

Should you be buying Clarivate stock or one of its competitors? The main competitors of Clarivate include Rentokil Initial (RTO), FTAI Aviation (FTAI), Maplebear (CART), ICON Public (ICLR), Stantec (STN), Medpace (MEDP), WPP (WPP), HealthEquity (HQY), Bilibili (BILI), and Lyft (LYFT). These companies are all part of the "business services" industry.

Clarivate vs.

Rentokil Initial (NYSE:RTO) and Clarivate (NYSE:CLVT) are both business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, community ranking and risk.

Rentokil Initial has higher revenue and earnings than Clarivate. Clarivate is trading at a lower price-to-earnings ratio than Rentokil Initial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rentokil Initial$5.44B2.19$473.93M$1.5115.63
Clarivate$2.53B1.18-$911.20M-$0.97-4.52

Rentokil Initial has a net margin of 0.00% compared to Clarivate's net margin of -24.90%. Clarivate's return on equity of 9.10% beat Rentokil Initial's return on equity.

Company Net Margins Return on Equity Return on Assets
Rentokil InitialN/A N/A N/A
Clarivate -24.90%9.10%3.93%

9.9% of Rentokil Initial shares are held by institutional investors. Comparatively, 85.7% of Clarivate shares are held by institutional investors. 23.2% of Clarivate shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Clarivate has a consensus price target of $5.00, suggesting a potential upside of 14.03%. Given Clarivate's higher possible upside, analysts plainly believe Clarivate is more favorable than Rentokil Initial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rentokil Initial
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.67
Clarivate
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Clarivate received 43 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 53.33% of users gave Clarivate an outperform vote while only 33.33% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
Rentokil InitialOutperform Votes
5
33.33%
Underperform Votes
10
66.67%
ClarivateOutperform Votes
48
53.33%
Underperform Votes
42
46.67%

In the previous week, Rentokil Initial had 6 more articles in the media than Clarivate. MarketBeat recorded 12 mentions for Rentokil Initial and 6 mentions for Clarivate. Rentokil Initial's average media sentiment score of 1.03 beat Clarivate's score of 0.51 indicating that Rentokil Initial is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rentokil Initial
8 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Clarivate
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Rentokil Initial has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, Clarivate has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500.

Summary

Rentokil Initial beats Clarivate on 11 of the 19 factors compared between the two stocks.

Get Clarivate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLVT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLVT vs. The Competition

MetricClarivateData processing & preparation IndustryComputer SectorNYSE Exchange
Market Cap$3.01B$4.42B$25.50B$19.72B
Dividend YieldN/A3.75%2.89%3.84%
P/E Ratio-4.5889.8245.2035.23
Price / Sales1.181,260.332,236.1234.07
Price / Cash2.8933.7434.7817.51
Price / Book0.596.466.804.79
Net Income-$911.20M$45.22M$738.65M$1.02B
7 Day Performance-1.24%-1.44%0.70%1.16%
1 Month Performance29.66%25.70%14.77%11.40%
1 Year Performance-26.12%19.84%52,433.76%5.56%

Clarivate Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLVT
Clarivate
1.7684 of 5 stars
$4.40
+2.3%
$5.00
+13.6%
-28.5%$3.01B$2.53B-4.5811,600
RTO
Rentokil Initial
2.0643 of 5 stars
$23.04
-1.0%
N/A-13.7%$11.63B$5.44B15.2562,900News Coverage
FTAI
FTAI Aviation
4.6734 of 5 stars
$112.96
+5.4%
$171.83
+52.1%
+56.4%$11.58B$1.91B-1,129.4940Positive News
CART
Maplebear
3.0077 of 5 stars
$43.61
-0.4%
$50.61
+16.0%
+33.4%$11.45B$3.38B29.273,380Positive News
Analyst Forecast
ICLR
ICON Public
4.4657 of 5 stars
$140.22
+4.7%
$215.33
+53.6%
-58.5%$11.32B$8.19B14.7141,100
STN
Stantec
2.3791 of 5 stars
$93.38
-1.0%
N/A+27.3%$10.65B$7.50B42.4526,000Trending News
Earnings Report
Dividend Increase
Analyst Revision
MEDP
Medpace
4.7795 of 5 stars
$313.74
+6.0%
$349.30
+11.3%
-22.2%$9.02B$2.16B24.845,200Positive News
WPP
WPP
2.1177 of 5 stars
$40.10
+1.9%
N/A-24.7%$8.65B$14.74B6.72115,500Gap Up
HQY
HealthEquity
3.2462 of 5 stars
$96.66
+6.9%
$111.75
+15.6%
+23.2%$8.36B$1.20B88.683,720Positive News
BILI
Bilibili
2.8622 of 5 stars
$18.86
+7.6%
$21.11
+11.9%
+7.8%$7.86B$26.83B-41.9112,300Trending News
Upcoming Earnings
Gap Up
LYFT
Lyft
3.7953 of 5 stars
$17.21
+3.4%
$16.56
-3.8%
+0.8%$7.19B$5.79B286.834,420High Trading Volume

Related Companies and Tools


This page (NYSE:CLVT) was last updated on 5/20/2025 by MarketBeat.com Staff
From Our Partners